Moritz von Scheidt

Dr. med. Dr. med. univ. Moritz von Scheidt

Cardiologist and Internist, German Heart Center Munich|TUM University Hospital - Deputy Scientific Management DigiMed Bayern

Moritz von Scheidt is a clinician scientist and cardiologist at the German Heart Center Munich of the Technical University of Munich. As a research fellow at the University of California Los Angeles (UCLA) he studied atherosclerosis in genetically engineered mouse models in direct comparison to human coronary artery disease supervised by Prof. Jake Lusis. He received an excellence grant from the German Centre of Cardiovascular Research (DZHK), third party funding by the German Society of Cardiology (DGK) and the German Heart Foundation (Deutsche Herzstiftung e.V.). In 2021 he received a young investigator award by the Leducq foundation and was awarded with the Uta and Jürgen Breunig Research Price for the mechanistic identification of the transcription factor MAFF as an inflammatory dependent regulator of the LDL-receptor. In 2022 he started his own Junior Research Group studying somatic mutations in cardiovascular disease funded with 1.0 million Euro by the CORONA Foundation. He is initiator and head of the MunIch CardiovaScular StudIes biObaNk (MISSION) – one of the largest human cardiovascular tissue biobanks with access to human coronary samples. His research aim includes the translation from genetics into functional biology, including the identification of biomarkers and potential treatment strategies.

speichern